{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/charles-river-laboratories/","json":"https://alysly.com/json/markets/stocks/charles-river-laboratories/index.json","lang":"en-US","title":"Charles River Laboratories International Inc. (CRL) Stock Price Today","description":"Charles River Laboratories International Inc. (CRL). Revenue $4.0bn, net margin -3.6% (FY ended Dec 2025). ISIN US1598641074.","modified":"2026-11-01T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/charles-river-laboratories/","json":"https://alysly.com/json/de/maerkte/aktien/charles-river-laboratories/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"Charles River Laboratories International Inc.","url":"https://alysly.com/markets/stocks/charles-river-laboratories/"}],"content":[{"type":"heading","level":1,"text":"Charles River Laboratories International Inc. (CRL)"},{"type":"paragraph","text":"CRL · Health Care · United States","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"United States","href":"https://alysly.com/markets/stocks/browse/?country=United%20States"}]},{"type":"paragraph","text":"Charles River Laboratories International Inc. (CRL) is a US company in the Health Care sector. The stock has its largest weight in XDEW (S&P 500 Equal Weight), at 0.26%. Anyone who holds an ETF containing Charles River Laboratories International also has an indirect stake in the company."},{"type":"heading","level":2,"id":"data","text":"Data and Charts: Charles River Laboratories International"},{"type":"heading","level":3,"text":"Key Data for Charles River Laboratories International"},{"type":"facts","items":[{"label":"Held in","value":"11 ETFs"},{"label":"Highest weight","value":"0.26%"},{"label":"Indices","value":"5"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"United States"},{"label":"ISIN","value":"US1598641074"}]},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":3,"text":"Charles River Laboratories International Stock Price Chart"},{"type":"paragraph","text":"The Charles River Laboratories International chart shows daily closing prices and is set to the current year by default. The stock is up 80.2% year to date and up 100.7% over twelve months. The last recorded close on October 30, 2026, was $359.41, at 93% of the 52-week range."},{"type":"paragraph","text":"Price series from our database since Aug 12, 2024, 558 daily values."},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"heading","level":3,"text":"Charles River Laboratories International Stock Performance"},{"type":"table","caption":"Charles River Laboratories International stock performance","rows":[["Year to date","+80.2%","1 year","+100.7%"],["1 month","+21.8%","3 months","+54.6%"],["Calendar year 2025","+8.1%","",""]]},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"paragraph","text":"Measured in euros, Charles River Laboratories International is up 89.5% year to date and up 107.5% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day."},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: Charles River Laboratories International"},{"type":"heading","level":3,"text":"What ETF Is Charles River Laboratories International In?"},{"type":"paragraph","text":"Charles River Laboratories International has average ETF coverage and is held by 11 of the 104 ETFs we track, which together follow 5 indices. That puts the stock in more ETFs than 66.9% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"table","caption":"What ETF is Charles River Laboratories International in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"XDEW","href":"https://alysly.com/markets/etfs/xtrackers-sp-500-equal-weight-ucits-etf-1c/"},{"text":"S&P 500 Equal Weight","href":"https://alysly.com/markets/indices/sp500-equal-weight/"},"0.26%","€2.63"],[{"text":"ZPRS / WDSD","links":[{"text":"ZPRS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-small-cap-ucits-etf-acc/"}]},{"text":"MSCI World Small Cap","href":"https://alysly.com/markets/indices/msci-world-small-cap/"},"0.18%","€1.76"],[{"text":"XSWC / XSWD","links":[{"text":"XSWC","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-small-cap-ucits-etf-1c/"}]},{"text":"MSCI World Small Cap","href":"https://alysly.com/markets/indices/msci-world-small-cap/"},"0.17%","€1.72"],[{"text":"SXR8","href":"https://alysly.com/markets/etfs/ishares-core-sp-500-ucits-etf-acc/"},{"text":"S&P 500","href":"https://alysly.com/markets/indices/sp500/"},"0.03%","€0.30"],[{"text":"SPYL / SPY5","links":[{"text":"SPYL","href":"https://alysly.com/markets/etfs/state-street-spdr-sp-500-ucits-etf-acc/"}]},{"text":"S&P 500","href":"https://alysly.com/markets/indices/sp500/"},"0.03%","€0.29"],[{"text":"WIMI","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-imi-ucits-etf-1c/"},{"text":"MSCI World IMI","href":"https://alysly.com/markets/indices/msci-world-imi/"},"0.02%","€0.16"],[{"text":"SPYI / SPSA","links":[{"text":"SPYI","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-investable-market-ucits-etf-acc/"}]},{"text":"MSCI ACWI IMI","href":"https://alysly.com/markets/indices/msci-acwi-imi/"},"< 0.01%","< €0.05"]]},{"type":"paragraph","text":"Data note 6","href":"#dn-6"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to Charles River Laboratories International, based on each fund's latest holdings list."},{"type":"paragraph","text":"US-listed ETFs holding Charles River Laboratories International (weight per latest SEC filing): IVV 0.02%, SPY 0.02%, VOO 0.02%, VTI 0.02%. These funds are registered in the US; retail investors in the EU usually cannot buy them.","links":[{"text":"IVV","href":"https://alysly.com/markets/etfs/us/ivv/"},{"text":"SPY","href":"https://alysly.com/markets/etfs/us/spy/"},{"text":"VOO","href":"https://alysly.com/markets/etfs/us/voo/"},{"text":"VTI","href":"https://alysly.com/markets/etfs/us/vti/"}]},{"type":"list","ordered":false,"items":[{"text":"Charles River Laboratories International among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 11 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"heading","level":3,"text":"Charles River Laboratories International Weight in iShares Core S&P 500 (SXR8) Since 2021"},{"type":"image","alt":"Charles River Laboratories International: weight in SXR8 0.05% → 0.03%"},{"type":"paragraph","text":"Jun 30, 2021 Oct 29, 2026"},{"type":"paragraph","text":"In iShares Core S&P 500 (SXR8), Charles River Laboratories International had a weight of 0.05% on Jun 30, 2021 and 0.03% on Oct 29, 2026. The fund tracks the S&P 500. Its share peaked at 0.06% on Sep 30, 2021. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.","links":[{"text":"iShares Core S&P 500 (SXR8)","href":"https://alysly.com/markets/etfs/ishares-core-sp-500-ucits-etf-acc/"},{"text":"S&P 500","href":"https://alysly.com/markets/indices/sp500/"}]},{"type":"paragraph","text":"Data note 7","href":"#dn-7"},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much Charles River Laboratories International overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"What Charles River Laboratories International Executives and Directors Traded Recently"},{"type":"table","caption":"Trades by executives and directors","columns":["Date","Person","Type","Shares","Price"],"rows":[["Oct 22, 2026","FOSTER JAMES C Director","Sell (plan)","24,042","$350.00"],["Oct 21, 2026","Parisotto Shannon M Officer, CEVP, Disc & Safety Assessment","Sell (plan)","2,156","$344.41"],["Oct 5, 2026","Parisotto Shannon M Officer, CEVP, Disc & Safety Assessment","Sell (plan)","981","$308.44"],["Sep 30, 2026","Coleman Glenn Officer, EVP & Chief Financial Officer","Buy","10","$297.43"]]},{"type":"paragraph","text":"The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded."},{"type":"paragraph","text":"“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32."},{"type":"paragraph","text":"Data note 8","href":"#dn-8"},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to Charles River Laboratories International"},{"type":"table","caption":"Stocks with ETF exposure similar to Charles River Laboratories International","columns":["Stock","Shared ETFs","r","1 year","Annualized volatility","Net margin","Revenue growth"],"rows":[["Charles River Laboratories International","–","–","+100.7%","49.3%","-3.6%","-0.9%"],[{"text":"Align Technology","href":"https://alysly.com/markets/stocks/align-technology-inc/"},"11","–","+8.3%","45.9%","10.2%","+0.9%"],[{"text":"Baxter International","href":"https://alysly.com/markets/stocks/baxter-international-inc/"},"11","–","+20.0%","40.8%","-8.5%","+5.7%"],[{"text":"DaVita","href":"https://alysly.com/markets/stocks/davita-inc/"},"11","-0.35","+57.9%","38.9%","5.5%","+6.5%"],[{"text":"Henry Schein","href":"https://alysly.com/markets/stocks/henry-schein-inc/"},"11","–","+34.9%","26.4%","3.0%","+4.0%"],[{"text":"Insulet Corporation","href":"https://alysly.com/markets/stocks/insulet-corporation/"},"11","–","-52.0%","40.8%","9.1%","+30.7%"],[{"text":"Revvity","href":"https://alysly.com/markets/stocks/revvity-inc/"},"11","+0.54","+72.5%","37.1%","8.4%","+3.7%"],[{"text":"Solventum Corporation","href":"https://alysly.com/markets/stocks/solventum-corporation/"},"11","–","+17.4%","29.8%","18.7%","+0.9%"],[{"text":"Bio-Techne Corporation","href":"https://alysly.com/markets/stocks/bio-techne-corporation/"},"11","–","+19.2%","42.5%","15.0%","-0.4%"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as Charles River Laboratories International. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical."},{"type":"paragraph","text":"Data note 9","href":"#dn-9"},{"type":"heading","level":2,"id":"fundamental","text":"Fundamental Analysis: Charles River Laboratories International"},{"type":"heading","level":3,"text":"Charles River Laboratories International Key Financials"},{"type":"facts","items":[{"label":"Revenue","value":"$4.0B"},{"label":"Net income","value":"-$144.3M"},{"label":"Diluted EPS","value":"-$2.91"},{"label":"Net margin","value":"-3.6%"},{"label":"Return on equity","value":"-4.6%"},{"label":"Equity ratio","value":"44.4%"},{"label":"Revenue growth","value":"-0.9%"}]},{"type":"paragraph","text":"Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 27, 2025)."},{"type":"table","caption":"Revenue and profit by fiscal year","columns":["Fiscal year","Revenue","Net income","Margin"],"rows":[["FY ended Dec 2023","4.1","0.5","11.5%"],["FY ended Dec 2024","4.0","0.0","0.5%"],["FY ended Dec 2025","4.0","-0.1","-3.6%"]]},{"type":"paragraph","text":"Data note 10","href":"#dn-10"},{"type":"heading","level":2,"id":"technical","text":"Technical Analysis: Charles River Laboratories International"},{"type":"heading","level":3,"text":"Charles River Laboratories International Risk Metrics"},{"type":"facts","items":[{"label":"Max drawdown","value":"-54.8%"},{"label":"Annualized volatility","value":"49.3%"}]},{"type":"paragraph","text":"Data note 11","href":"#dn-11"},{"type":"facts","items":[{"label":"Below peak","value":"-4.4%"},{"label":"Beta to S&P 500","value":"1.31"},{"label":"Correlation to S&P 500","value":"0.36"}]},{"type":"paragraph","text":"The close on Oct 30, 2026, was 4.4% below the highest close since Aug 12, 2024. That high was reached on Oct 29, 2026. When the S&P 500 rose or fell 1%, Charles River Laboratories International moved 1.31% on average in the same direction (past 252 trading days). The correlation of 0.36, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Charles River Laboratories International."},{"type":"paragraph","text":"Data note 12","href":"#dn-12"},{"type":"heading","level":3,"text":"What Charles River Laboratories International Correlates With"},{"type":"table","caption":"What Charles River Laboratories International Correlates With","columns":["Instrument","r","−1 … +1"],"rows":[[{"text":"Waters Corporation","href":"https://alysly.com/markets/stocks/waters-corporation/"},"+0.66",""],[{"text":"Agilent Technologies Inc.","href":"https://alysly.com/markets/stocks/agilent-technologies-inc/"},"+0.61",""],[{"text":"IQVIA Holdings Inc","href":"https://alysly.com/markets/stocks/iqvia-holdings-inc/"},"+0.60",""],[{"text":"Thermo Fisher Scientific Inc.","href":"https://alysly.com/markets/stocks/thermo-fisher-scientific-inc/"},"+0.58",""],[{"text":"Illumina Inc.","href":"https://alysly.com/markets/stocks/illumina-inc/"},"+0.54",""],[{"text":"Revvity Inc.","href":"https://alysly.com/markets/stocks/revvity-inc/"},"+0.54",""],[{"text":"DaVita Inc.","href":"https://alysly.com/markets/stocks/davita-inc/"},"-0.35",""],[{"text":"SAPIEN","href":"https://alysly.com/markets/crypto/sapien/"},"-0.31",""],[{"text":"YB","href":"https://alysly.com/markets/crypto/yb/"},"-0.28",""]]},{"type":"paragraph","text":"The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio."},{"type":"paragraph","text":"Data note 13","href":"#dn-13"},{"type":"heading","level":2,"id":"refs","text":"Related Content: Charles River Laboratories International"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 1, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-2","text":"Price history from daily closing prices; one point per trading day."},{"id":"dn-3","text":"Returns computed automatically from the price series, excluding dividends, taxes and costs."},{"id":"dn-4","text":"Daily dollar prices converted at the same day's ECB euro reference rate, then measured like the dollar return."},{"id":"dn-5","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-6","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-7","text":"From the fund's published holdings lists at each quarter end, plus the latest date."},{"id":"dn-8","text":"Purchases and sales by directors, officers and ten-percent owners from Form 4 filings with the US securities regulator, reported two trading days after the transaction."},{"id":"dn-9","text":"Selected by how many of the funds we track hold both names, not by business model."},{"id":"dn-10","text":"Latest reported fiscal year from XBRL annual filings with the SEC (public domain), figures in billions of US dollars; ratios computed from them."},{"id":"dn-11","text":"Computed from the full available price history."},{"id":"dn-12","text":"From daily closes: distance from the series' highest close; beta and correlation of daily returns to the S&P 500 over the last 252 trading days."},{"id":"dn-13","text":"Co-movement of daily returns over the last 90 trading days, across asset classes."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/charles-river-laboratories/#webpage","url":"https://alysly.com/markets/stocks/charles-river-laboratories/","name":"Charles River Laboratories International Inc. – Alysly","description":"Charles River Laboratories International Inc. (CRL). Revenue $4.0bn, net margin -3.6% (FY ended Dec 2025). ISIN US1598641074.","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-01T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/charles-river-laboratories/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"Charles River Laboratories International Inc."}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/charles-river-laboratories/#entity","name":"Charles River Laboratories International Inc.","tickerSymbol":"CRL","url":"https://alysly.com/markets/stocks/charles-river-laboratories/","mainEntityOfPage":"https://alysly.com/markets/stocks/charles-river-laboratories/","description":"Charles River Laboratories International Inc. (CRL). Revenue $4.0bn, net margin -3.6% (FY ended Dec 2025). ISIN US1598641074.","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"CRL"},{"@type":"PropertyValue","propertyID":"ISIN","value":"US1598641074"}],"address":{"@type":"PostalAddress","addressCountry":"US"},"subjectOf":{"@type":"Dataset","name":"Charles River Laboratories International Inc. — key figures","url":"https://alysly.com/markets/stocks/charles-river-laboratories/","description":"Charles River Laboratories International Inc. (CRL). Revenue $4.0bn, net margin -3.6% (FY ended Dec 2025). ISIN US1598641074.","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":11},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":0.2629},{"@type":"PropertyValue","name":"YTD return (%)","value":80.2},{"@type":"PropertyValue","name":"1-year return (%)","value":100.7},{"@type":"PropertyValue","name":"Sector","value":"Health Care"},{"@type":"PropertyValue","name":"Revenue (USD)","unitText":"USD","value":4015382000.0},{"@type":"PropertyValue","name":"Net income (USD)","unitText":"USD","value":-144338000.0},{"@type":"PropertyValue","name":"Total assets (USD)","unitText":"USD","value":7135422000.0},{"@type":"PropertyValue","name":"Shareholders equity (USD)","unitText":"USD","value":3164630000.0},{"@type":"PropertyValue","name":"Diluted EPS (USD)","value":-2.91},{"@type":"PropertyValue","name":"Net margin (%)","value":-3.5999999999999996},{"@type":"PropertyValue","name":"Return on equity (%)","value":-4.6},{"@type":"PropertyValue","name":"Fiscal year end","value":"2025-12-27"}],"temporalCoverage":"2024-08-12/.."}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}